Back to Journals » Drug Design, Development and Therapy » Volume 10

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

Total article views   HTML views PDF downloads Totals
14,678 Dovepress* 12,697+ 1,381 14,078
PubMed Central* 1,981 557 2,538
Totals 14,678 1,938 16,616
*Since 30 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
19 1 0 0 7 11

View citations on PubMed Central and Google Scholar